{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-063262","form_type":"8-K","ticker":"CBIO","cik":"0001253689","company_name":"CRESCENT BIOPHARMA, INC.","filed_at":"2022-05-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:59.998532+00:00","generated_at":"2026-06-25T08:36:33.679445+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"GlycoMimetics stockholders approve 2.6M share increase to equity incentive plan","bullets":["Stockholders approved amendment to 2013 Equity Incentive Plan, increasing share reserve by 2,619,622 shares.","All three director nominees (Scott Jackson, Scott Koenig, Harout Semerjian) were elected.","Ratification of Ernst & Young as independent auditor passed with 38,971,830 votes for.","Advisory vote on executive compensation approved with 27,132,991 votes for.","Annual meeting had 75% of shares present or represented."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-063262","json":"https://secwatch.observer/filing/0001104659-22-063262.json","markdown":"https://secwatch.observer/filing/0001104659-22-063262.md","text":"https://secwatch.observer/filing/0001104659-22-063262.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1253689/000110465922063262/0001104659-22-063262-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1253689/000110465922063262/tm2216126d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T08:36:33.679445+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}